BEAM regimen (busulfan, cyclophosphamide, etoposide, cytarabine)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for BEAM regimen (busulfan, cyclophosphamide, etoposide, cytarabine), covering 2022-06-22 to 2022-06-22. Get the full timeline:
Most recent: Clinical Trial Update: A Trial Comparing Single Agent Melphalan to Carmustine, Etoposide, Cytarabine, and Melphalan (BEAM) as a Preparative Regimen for Patients With Multiple Myeloma Undergoing High Dose Therapy Followed by Autologous Stem Cell Reinfusion [Phase 2]